JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 28, 2006; DOI: 10.1124/jpet.106.114165


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.114165v1
320/2/951    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penumathsa, S. V.
Right arrow Articles by Maulik, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penumathsa, S. V.
Right arrow Articles by Maulik, N.


Received for publication September 21, 2006.
Revised November 20, 2006.
Accepted for publication November 21, 2006.

SECOISOLARICIRESINOL DIGLUCOSIDE (SDG): RELEVANCE TO ANGIOGENESIS AND CARDIOPROTECTION AGAINST ISCHEMIA- REPERFUSION INJURY

Suresh Varma Penumathsa 1, Srikanth Koneru 1, Mahesh Thirunavukkarasu 1, Lijun Zhan 1, Kailash Prasad 2, Nilanjana Maulik 1*

1 University of Connecticut Medical Center 2 University of Saskatoon

* Address correspondence to: E-mail: nmaulik{at}neuron.uchc.edu

Abstract

Therapeutic angiogenesis represents a novel approach for the prevention and treatment of ischemic heart disease. This study examined a novel method of stimulating myocardial angiogenesis using secoisolariciresinol diglucoside (SDG), a plant lignan isolated from flax seed. SDG has been shown to lower serum cholesterol and reduce the extent of atherosclerosis. In the present study, the angiogenic properties of SDG were investigated in three different models: 1) In vitro model, human coronary arteriolar endothelial cells (HCAEC) treated with SDG (50 & 100 µM) showed a significant increase in tubulogenesis compared to control. Western blot indicated an increased expression of VEGF, KDR, Flt-1, angiopoietin-1 (Ang-1), Tie-1 and phosphorylated eNOS (p-eNOS) in the SDG-treated cells 2) In ex vivo ischemia/reperfusion (I/R) model, SDG-treated rats (20 mg/kg b wt/day for 2 weeks orally) showed an increased level of aortic flow & functional recovery after 2 hr of reperfusion following 30 min of ischemia compared to the control group [dp/dt (mm Hg/sec) of 2110 ± 35 vs 1752 ± 62]. SDG reduced infarct size compared to the control group by 32% (38% vs 26%) and also decreased cardiomyocyte apoptosis. Increased protein expression of VEGF, Ang-1 and p-eNOS was also observed in the SDG-treated group 3) In in vivo myocardial infarction (MI) model, SDG increased capillary density and myocardial function as evidenced by increased fractional shortening and ejection fraction, assessed by echocardiogram. In conclusion, these results suggest that SDG has potent angiogenic and anti-apoptotic properties that may contribute to its cardioprotective effect in ischemic models.


Key words: Angiogenesis, Echocardiogram, VEGF, heart disease, infarct size, secoisolariciresinol diglucoside


This article has been cited by other articles:


Home page
IOVSHome page
Z. Sameermahmood, M. Balasubramanyam, T. Saravanan, and M. Rema
Curcumin Modulates SDF-1{alpha}/CXCR4-Induced Migration of Human Retinal Endothelial Cells (HRECs)
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3305 - 3311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Juhasz, M. Thirunavukkarasu, R. Pant, L. Zhan, S. V. Penumathsa, E. R. Secor Jr., S. Srivastava, U. Raychaudhuri, V. P. Menon, H. Otani, et al.
Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1365 - H1370.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.